BiotechTube
Home/Chugai Pharmaceutical/Dr. Hiroshi Eda
DH

Dr. Hiroshi Eda

Executive Vice President, Head of Chugai Research Institute for Medical Science, Inc.

Chugai Pharmaceutical

Therapeutic Areas

OncologyHematologyImmunologyNeuroscience

Chugai Pharmaceutical Pipeline

DrugIndicationPhase
GantenerumabAlzheimer's DiseasePhase III
TiragolumabNon-Small Cell Lung CancerPhase III
CrovalimabParoxysmal Nocturnal HemoglobinuriaPhase III / Marketed
RG6525 (IL-36R Ab)Generalized Pustular PsoriasisPhase III
RG6139 (RO7247669)Hepatocellular CarcinomaPhase III
RG6356 (RO7434656)Acute Myeloid LeukemiaPhase III
RG7841 (FAP-4-1BBL)Solid TumorsPhase I/II

Leadership Team at Chugai Pharmaceutical

DO
Dr. Osamu Okuda
President and CEO
DY
Dr. Yutaka Tanaka
Vice Chairman
DY
Dr. Yasushi Ito
Executive Vice President, Co-Head of Project & Lifecycle Management Unit
View full Chugai Pharmaceutical profile